Cargando…

Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype

Detalles Bibliográficos
Autores principales: He, Qing, Jing, Hongyu, Liaw, Lucy, Gower, Lindsey, Vary, Calvin, Hua, Shucheng, Yang, Xuehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411808/
https://www.ncbi.nlm.nih.gov/pubmed/28462917
http://dx.doi.org/10.1038/srep46791
_version_ 1783232866277130240
author He, Qing
Jing, Hongyu
Liaw, Lucy
Gower, Lindsey
Vary, Calvin
Hua, Shucheng
Yang, Xuehui
author_facet He, Qing
Jing, Hongyu
Liaw, Lucy
Gower, Lindsey
Vary, Calvin
Hua, Shucheng
Yang, Xuehui
author_sort He, Qing
collection PubMed
description
format Online
Article
Text
id pubmed-5411808
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-54118082017-05-03 Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype He, Qing Jing, Hongyu Liaw, Lucy Gower, Lindsey Vary, Calvin Hua, Shucheng Yang, Xuehui Sci Rep Corrigenda Nature Publishing Group 2017-05-02 /pmc/articles/PMC5411808/ /pubmed/28462917 http://dx.doi.org/10.1038/srep46791 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Corrigenda
He, Qing
Jing, Hongyu
Liaw, Lucy
Gower, Lindsey
Vary, Calvin
Hua, Shucheng
Yang, Xuehui
Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
title Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
title_full Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
title_fullStr Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
title_full_unstemmed Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
title_short Corrigendum: Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype
title_sort corrigendum: suppression of spry1 inhibits triple-negative breast cancer malignancy by decreasing egf/egfr mediated mesenchymal phenotype
topic Corrigenda
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411808/
https://www.ncbi.nlm.nih.gov/pubmed/28462917
http://dx.doi.org/10.1038/srep46791
work_keys_str_mv AT heqing corrigendumsuppressionofspry1inhibitstriplenegativebreastcancermalignancybydecreasingegfegfrmediatedmesenchymalphenotype
AT jinghongyu corrigendumsuppressionofspry1inhibitstriplenegativebreastcancermalignancybydecreasingegfegfrmediatedmesenchymalphenotype
AT liawlucy corrigendumsuppressionofspry1inhibitstriplenegativebreastcancermalignancybydecreasingegfegfrmediatedmesenchymalphenotype
AT gowerlindsey corrigendumsuppressionofspry1inhibitstriplenegativebreastcancermalignancybydecreasingegfegfrmediatedmesenchymalphenotype
AT varycalvin corrigendumsuppressionofspry1inhibitstriplenegativebreastcancermalignancybydecreasingegfegfrmediatedmesenchymalphenotype
AT huashucheng corrigendumsuppressionofspry1inhibitstriplenegativebreastcancermalignancybydecreasingegfegfrmediatedmesenchymalphenotype
AT yangxuehui corrigendumsuppressionofspry1inhibitstriplenegativebreastcancermalignancybydecreasingegfegfrmediatedmesenchymalphenotype